 | • レポートコード：QFJ1-5772 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、血管腫の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、レーザー治療、手術、その他）、用途別市場規模（大人用、子供用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・血管腫の市場動向 ・企業の競争状況、市場シェア ・血管腫の種類別市場規模と予測2016-2027（医療、レーザー治療、手術、その他） ・血管腫の用途別市場規模と予測2016-2027（大人用、子供用） ・血管腫の北米市場規模2016-2027（アメリカ、カナダ） ・血管腫の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・血管腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血管腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・血管腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Akrimax、AstraZeneca、Novartis、Cutting Edge Laser Technologies、Pfizer、Pierre Fabre） ・結論 |
Hemangioma is the birthmark or benign tumors of infancy that occurs due to an abnormal collection of blood vessels. This occurs in 5-10% of infants worldwide.
Market Analysis and Insights: Global Hemangioma Market
The global Hemangioma market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hemangioma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hemangioma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hemangioma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hemangioma market.
Global Hemangioma Scope and Market Size
Hemangioma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemangioma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medical Therapy
Laser Therapy
Surgery
Other
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Akrimax
AstraZeneca
Novartis
Cutting Edge Laser Technologies
Pfizer
Pierre Fabre
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemangioma Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medical Therapy
1.2.3 Laser Therapy
1.2.4 Surgery
1.2.5 Other
1.3 Market by Application
1.3.1 Global Hemangioma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hemangioma Market Perspective (2016-2027)
2.2 Hemangioma Growth Trends by Regions
2.2.1 Hemangioma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hemangioma Historic Market Share by Regions (2016-2021)
2.2.3 Hemangioma Forecasted Market Size by Regions (2022-2027)
2.3 Hemangioma Industry Dynamic
2.3.1 Hemangioma Market Trends
2.3.2 Hemangioma Market Drivers
2.3.3 Hemangioma Market Challenges
2.3.4 Hemangioma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemangioma Players by Revenue
3.1.1 Global Top Hemangioma Players by Revenue (2016-2021)
3.1.2 Global Hemangioma Revenue Market Share by Players (2016-2021)
3.2 Global Hemangioma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hemangioma Revenue
3.4 Global Hemangioma Market Concentration Ratio
3.4.1 Global Hemangioma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemangioma Revenue in 2020
3.5 Hemangioma Key Players Head office and Area Served
3.6 Key Players Hemangioma Product Solution and Service
3.7 Date of Enter into Hemangioma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemangioma Breakdown Data by Type
4.1 Global Hemangioma Historic Market Size by Type (2016-2021)
4.2 Global Hemangioma Forecasted Market Size by Type (2022-2027)
5 Hemangioma Breakdown Data by Application
5.1 Global Hemangioma Historic Market Size by Application (2016-2021)
5.2 Global Hemangioma Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hemangioma Market Size (2016-2027)
6.2 North America Hemangioma Market Size by Type
6.2.1 North America Hemangioma Market Size by Type (2016-2021)
6.2.2 North America Hemangioma Market Size by Type (2022-2027)
6.2.3 North America Hemangioma Market Size by Type (2016-2027)
6.3 North America Hemangioma Market Size by Application
6.3.1 North America Hemangioma Market Size by Application (2016-2021)
6.3.2 North America Hemangioma Market Size by Application (2022-2027)
6.3.3 North America Hemangioma Market Size by Application (2016-2027)
6.4 North America Hemangioma Market Size by Country
6.4.1 North America Hemangioma Market Size by Country (2016-2021)
6.4.2 North America Hemangioma Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hemangioma Market Size (2016-2027)
7.2 Europe Hemangioma Market Size by Type
7.2.1 Europe Hemangioma Market Size by Type (2016-2021)
7.2.2 Europe Hemangioma Market Size by Type (2022-2027)
7.2.3 Europe Hemangioma Market Size by Type (2016-2027)
7.3 Europe Hemangioma Market Size by Application
7.3.1 Europe Hemangioma Market Size by Application (2016-2021)
7.3.2 Europe Hemangioma Market Size by Application (2022-2027)
7.3.3 Europe Hemangioma Market Size by Application (2016-2027)
7.4 Europe Hemangioma Market Size by Country
7.4.1 Europe Hemangioma Market Size by Country (2016-2021)
7.4.2 Europe Hemangioma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hemangioma Market Size (2016-2027)
8.2 Asia-Pacific Hemangioma Market Size by Type
8.2.1 Asia-Pacific Hemangioma Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hemangioma Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hemangioma Market Size by Type (2016-2027)
8.3 Asia-Pacific Hemangioma Market Size by Application
8.3.1 Asia-Pacific Hemangioma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hemangioma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hemangioma Market Size by Application (2016-2027)
8.4 Asia-Pacific Hemangioma Market Size by Region
8.4.1 Asia-Pacific Hemangioma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hemangioma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hemangioma Market Size (2016-2027)
9.2 Latin America Hemangioma Market Size by Type
9.2.1 Latin America Hemangioma Market Size by Type (2016-2021)
9.2.2 Latin America Hemangioma Market Size by Type (2022-2027)
9.2.3 Latin America Hemangioma Market Size by Type (2016-2027)
9.3 Latin America Hemangioma Market Size by Application
9.3.1 Latin America Hemangioma Market Size by Application (2016-2021)
9.3.2 Latin America Hemangioma Market Size by Application (2022-2027)
9.3.3 Latin America Hemangioma Market Size by Application (2016-2027)
9.4 Latin America Hemangioma Market Size by Country
9.4.1 Latin America Hemangioma Market Size by Country (2016-2021)
9.4.2 Latin America Hemangioma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemangioma Market Size (2016-2027)
10.2 Middle East & Africa Hemangioma Market Size by Type
10.2.1 Middle East & Africa Hemangioma Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hemangioma Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hemangioma Market Size by Type (2016-2027)
10.3 Middle East & Africa Hemangioma Market Size by Application
10.3.1 Middle East & Africa Hemangioma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hemangioma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hemangioma Market Size by Application (2016-2027)
10.4 Middle East & Africa Hemangioma Market Size by Country
10.4.1 Middle East & Africa Hemangioma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hemangioma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Akrimax
11.1.1 Akrimax Company Details
11.1.2 Akrimax Business Overview
11.1.3 Akrimax Hemangioma Introduction
11.1.4 Akrimax Revenue in Hemangioma Business (2016-2021)
11.1.5 Akrimax Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Hemangioma Introduction
11.2.4 AstraZeneca Revenue in Hemangioma Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Hemangioma Introduction
11.3.4 Novartis Revenue in Hemangioma Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Cutting Edge Laser Technologies
11.4.1 Cutting Edge Laser Technologies Company Details
11.4.2 Cutting Edge Laser Technologies Business Overview
11.4.3 Cutting Edge Laser Technologies Hemangioma Introduction
11.4.4 Cutting Edge Laser Technologies Revenue in Hemangioma Business (2016-2021)
11.4.5 Cutting Edge Laser Technologies Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Hemangioma Introduction
11.5.4 Pfizer Revenue in Hemangioma Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Pierre Fabre
11.6.1 Pierre Fabre Company Details
11.6.2 Pierre Fabre Business Overview
11.6.3 Pierre Fabre Hemangioma Introduction
11.6.4 Pierre Fabre Revenue in Hemangioma Business (2016-2021)
11.6.5 Pierre Fabre Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hemangioma Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medical Therapy
Table 3. Key Players of Laser Therapy
Table 4. Key Players of Surgery
Table 5. Key Players of Other
Table 6. Global Hemangioma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hemangioma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hemangioma Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Hemangioma Market Share by Regions (2016-2021)
Table 10. Global Hemangioma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Hemangioma Market Share by Regions (2022-2027)
Table 12. Hemangioma Market Trends
Table 13. Hemangioma Market Drivers
Table 14. Hemangioma Market Challenges
Table 15. Hemangioma Market Restraints
Table 16. Global Hemangioma Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Hemangioma Market Share by Players (2016-2021)
Table 18. Global Top Hemangioma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemangioma as of 2020)
Table 19. Ranking of Global Top Hemangioma Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Hemangioma Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hemangioma Product Solution and Service
Table 23. Date of Enter into Hemangioma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hemangioma Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Hemangioma Revenue Market Share by Type (2016-2021)
Table 27. Global Hemangioma Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Hemangioma Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Hemangioma Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Hemangioma Revenue Market Share by Application (2016-2021)
Table 31. Global Hemangioma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Hemangioma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Hemangioma Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Hemangioma Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Hemangioma Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Hemangioma Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Hemangioma Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Hemangioma Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Hemangioma Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Hemangioma Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Hemangioma Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Hemangioma Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Hemangioma Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Hemangioma Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hemangioma Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hemangioma Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hemangioma Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Hemangioma Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Hemangioma Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Hemangioma Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Hemangioma Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Hemangioma Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Hemangioma Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Hemangioma Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Hemangioma Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Hemangioma Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hemangioma Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hemangioma Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hemangioma Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Hemangioma Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Hemangioma Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Hemangioma Market Size by Country (2022-2027) & (US$ Million)
Table 63. Akrimax Company Details
Table 64. Akrimax Business Overview
Table 65. Akrimax Hemangioma Product
Table 66. Akrimax Revenue in Hemangioma Business (2016-2021) & (US$ Million)
Table 67. Akrimax Recent Development
Table 68. AstraZeneca Company Details
Table 69. AstraZeneca Business Overview
Table 70. AstraZeneca Hemangioma Product
Table 71. AstraZeneca Revenue in Hemangioma Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Hemangioma Product
Table 76. Novartis Revenue in Hemangioma Business (2016-2021) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Cutting Edge Laser Technologies Company Details
Table 79. Cutting Edge Laser Technologies Business Overview
Table 80. Cutting Edge Laser Technologies Hemangioma Product
Table 81. Cutting Edge Laser Technologies Revenue in Hemangioma Business (2016-2021) & (US$ Million)
Table 82. Cutting Edge Laser Technologies Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Hemangioma Product
Table 86. Pfizer Revenue in Hemangioma Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Pierre Fabre Company Details
Table 89. Pierre Fabre Business Overview
Table 90. Pierre Fabre Hemangioma Product
Table 91. Pierre Fabre Revenue in Hemangioma Business (2016-2021) & (US$ Million)
Table 92. Pierre Fabre Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemangioma Market Share by Type: 2020 VS 2027
Figure 2. Medical Therapy Features
Figure 3. Laser Therapy Features
Figure 4. Surgery Features
Figure 5. Other Features
Figure 6. Global Hemangioma Market Share by Application: 2020 VS 2027
Figure 7. Adult Case Studies
Figure 8. Child Case Studies
Figure 9. Hemangioma Report Years Considered
Figure 10. Global Hemangioma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hemangioma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hemangioma Market Share by Regions: 2020 VS 2027
Figure 13. Global Hemangioma Market Share by Regions (2022-2027)
Figure 14. Global Hemangioma Market Share by Players in 2020
Figure 15. Global Top Hemangioma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemangioma as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hemangioma Revenue in 2020
Figure 17. Global Hemangioma Revenue Market Share by Type (2016-2021)
Figure 18. Global Hemangioma Revenue Market Share by Type (2022-2027)
Figure 19. North America Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hemangioma Market Share by Type (2016-2027)
Figure 21. North America Hemangioma Market Share by Application (2016-2027)
Figure 22. North America Hemangioma Market Share by Country (2016-2027)
Figure 23. United States Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hemangioma Market Share by Type (2016-2027)
Figure 27. Europe Hemangioma Market Share by Application (2016-2027)
Figure 28. Europe Hemangioma Market Share by Country (2016-2027)
Figure 29. Germany Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hemangioma Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hemangioma Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hemangioma Market Share by Region (2016-2027)
Figure 39. China Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hemangioma Market Share by Type (2016-2027)
Figure 47. Latin America Hemangioma Market Share by Application (2016-2027)
Figure 48. Latin America Hemangioma Market Share by Country (2016-2027)
Figure 49. Mexico Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hemangioma Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hemangioma Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hemangioma Market Share by Country (2016-2027)
Figure 55. Turkey Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hemangioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Akrimax Revenue Growth Rate in Hemangioma Business (2016-2021)
Figure 59. AstraZeneca Revenue Growth Rate in Hemangioma Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Hemangioma Business (2016-2021)
Figure 61. Cutting Edge Laser Technologies Revenue Growth Rate in Hemangioma Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Hemangioma Business (2016-2021)
Figure 63. Pierre Fabre Revenue Growth Rate in Hemangioma Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の眼科エキシマレーザー治療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ophthalmology Excimer Laser Therapy Solutions Market The global Ophthalmology Excimer Laser Therapy Solutions market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…- 世界の重粒子線治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Heavy Ion Therapy Market The global Heavy Ion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界の脊髄刺激療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Spinal Cord Stimulation Therapy Market The global Spinal Cord Stimulation Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
- 世界の圧迫衣類療法市場規模・現状・予測（2021年-2027年） The presence of a large number of target patients and the rising incidence of sports injuries and accidents are the main factors driving the growth of the compression therapy market. Based on products, the compression therapy market is segmented into compression garments, compression correctors and …
- 世界の補助療法市場規模・現状・予測（2021年-2027年） Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal. Market Analysis and Insights: Global Adjuvant Therapy Market The global Adjuvant Therapy market size is…